| Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension BVIF de Franchis, Roberto Journal of Hepatology 63 (3), 743-52, 2015 | 4034 | 2015 |
| EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis P Angeli, M Bernardi, C Villanueva, C Francoz, RP Mookerjee, J Trebicka, ... Journal of hepatology 69 (2), 406-460, 2018 | 2647 | 2018 |
| Baveno VII–renewing consensus in portal hypertension R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ... Journal of hepatology 76 (4), 959-974, 2022 | 2061 | 2022 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1211 | 2019 |
| Liver cirrhosis P Ginès, A Krag, JG Abraldes, E Solà, N Fabrellas, PS Kamath The Lancet 398 (10308), 1359-1376, 2021 | 1157 | 2021 |
| Spontaneous bacterial peritonitis: recent guidelines and beyond R Wiest, A Krag, A Gerbes Gut 61 (2), 297-310, 2012 | 527 | 2012 |
| Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis E Herrmann, V de Lédinghen, C Cassinotto, WCW Chu, VYF Leung, ... Hepatology 67 (1), 260-272, 2018 | 500 | 2018 |
| Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites A Krag, F Bendtsen, JH Henriksen, S Møller Gut 59 (01), 105-110, 2010 | 482 | 2010 |
| Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ... Gastroenterology 156 (5), 1368-1380. e10, 2019 | 463 | 2019 |
| Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome LL Gluud, K Christensen, E Christensen, A Krag Hepatology 51 (2), 576-584, 2010 | 420 | 2010 |
| The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease A Krag, R Wiest, A Albillos, LL Gluud Gut 61 (7), 967-969, 2012 | 272 | 2012 |
| Novel insights into the function and dynamics of extracellular matrix in liver fibrosis MA Karsdal, T Manon-Jensen, F Genovese, JH Kristensen, MJ Nielsen, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 308 (10 …, 2015 | 264 | 2015 |
| Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease M Thiele, BS Madsen, JF Hansen, S Detlefsen, S Antonsen, A Krag Gastroenterology 154 (5), 1369-1379, 2018 | 258 | 2018 |
| Banding ligation versus beta‐blockers for primary prevention in oesophageal varices in adults LL Gluud, A Krag Cochrane Database of Systematic Reviews, 2012 | 258 | 2012 |
| Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis M Thiele, S Detlefsen, LS Møller, BS Madsen, JF Hansen, AD Fialla, ... Gastroenterology 150 (1), 123-133, 2016 | 253 | 2016 |
| Terlipressin for hepatorenal syndrome LL Gluud, K Christensen, E Christensen, A Krag Cochrane Database of Systematic Reviews, 2012 | 253 | 2012 |
| ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis SJ Daniels, DJ Leeming, M Eslam, AM Hashem, MJ Nielsen, A Krag, ... Hepatology 69 (3), 1075-1086, 2019 | 241 | 2019 |
| Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy N Kimer, A Krag, S Møller, F Bendtsen, LL Gluud Alimentary pharmacology & therapeutics 40 (2), 123-132, 2014 | 236 | 2014 |
| Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis M Simón-Talero, D Roccarina, J Martínez, K Lampichler, A Baiges, G Low, ... Gastroenterology 154 (6), 1694-1705. e4, 2018 | 235 | 2018 |
| Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis D Petroff, V Blank, PN Newsome, CS Voican, M Thiele, V de Lédinghen, ... The Lancet Gastroenterology & Hepatology 6 (3), 185-198, 2021 | 213 | 2021 |
Maja Thiele, MD, PhD, professorCenter for Liver Research, Odense University HospitalAdresse e-mail validée de dadlnet.dk